Topiramate 51655-0746-52
- Manufacturer
- Northwind Health Company, Llc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 30, 2022
- Listing Expires
- December 31, 2027
- Application
- ANDA078235
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 50 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
51655-0746-52Selected30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-746-52)
Other packages for this product(1)
90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-746-26)